elara semaglutide Don't See Generic Competition In The US For Till 2030-2031: Capital Physician-Guided GLP-1 Weight Loss |

Not for human or animal consumption, and not intended to diagnose, treat, cure or prevent any disease

Setting 194 sites

As a leading telemedicine weight loss provider, we offer these advanced treatments without the need for insurance

Learn your Semaglutide options.

Noom breaks the GLP-1 cost cycle with two innovative solutions Noom is tackling the problem of GLP-1 availability, accessibility and inflated costs by launching two distinct solutions for employers that reduce obesity management costs while enabling access to life-changing medications: Noom Med with SmartRx in partnership with Waltz Health, and Noom Weight with GLP-1Rx